Stock VEXT VEXT SCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Vext Science, Inc.

Equities

VEXT

CA9255401064

Delayed Canadian Securities Exchange
Other stock markets
 09:37:58 2024-04-29 am EDT 		5-day change 1st Jan Change
0.245 CAD +2.08% Intraday chart for Vext Science, Inc. 0.00% -15.52%
Jan. 16 Vext Science, Inc. Announces Transition of Jason Thai Nguyen Out of Executive Role CI
2023 Vext Science, Inc. Announces Board Changes CI

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Analyst opinion has improved significantly over the past four months.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • One of the major weak points of the company is its financial situation.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
VEXT SCIENCE, INC. Stock Vext Science, Inc.
-15.52% 43.03M -
ASCEND WELLNESS HOLDINGS, INC. Stock Ascend Wellness Holdings, Inc.
+28.87% 272M -
AYR WELLNESS INC. Stock Ayr Wellness Inc.
+44.03% 261M -
ORGANIGRAM HOLDINGS INC. Stock Organigram Holdings Inc.
+48.26% 194M
C
JUSHI HOLDINGS INC. Stock Jushi Holdings Inc.
+48.59% 131M -
IANTHUS CAPITAL HOLDINGS, INC. Stock iAnthus Capital Holdings, Inc.
-28.57% 121M - -
INTERCURE LTD. Stock InterCure Ltd.
+115.91% 119M - -
THE CANNABIST COMPANY HOLDINGS INC. Stock The Cannabist Company Holdings Inc.
-37.37% 119M
C
4FRONT VENTURES CORP. Stock 4Front Ventures Corp.
-3.85% 86.82M - -
BAKHU HOLDINGS, CORP. Stock Bakhu Holdings, Corp.
+150.00% 75.33M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. VEXT Stock
  4. Ratings Vext Science, Inc.